Gliclazide + Metformin + Rosiglitazone
Information about Gliclazide + Metformin + Rosiglitazone
Gliclazide + metformin + rosiglitazone uses
Gliclazide+Metformin+Rosiglitazone is used in the treatment of type 2 diabetes.
How gliclazide + metformin + rosiglitazone works
This is a combination of three antidiabetic medicines: Gliclazide, Metformin and Rosiglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Gliclazide is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Rosiglitazone is a thiazolidinedione which further increases insulin sensitivity.
Common side effects of gliclazide + metformin + rosiglitazone
Hypoglycemia (low blood sugar level), Nausea, Altered taste, Diarrhoea, Stomach pain, Headache, Edema (swelling), Weight gain, Blurred vision, Bone fracture, Respiratory tract infection
Available Medicine for Gliclazide + Metformin + Rosiglitazone
- ₹49Bal Pharma Ltd1 variant(s)